semaglutide overseas shortage ends as FDA sets deadline for compounders Frequently Asked Questions | Ozempic®

Retatrutide is not a prescription drug in Canada because it has not been approved by Health Canada

Sattar et al., 2021) (Table 2)

The semaglutide known as Ozempic is intended to be used for people with diabetes

Contraindications Noted in Published Research Because IGF-1 signaling operates through cellular proliferation pathways also implicated in oncogenic processes, the literature consistently identifies active or prior malignancy, and precancerous conditions, as contraindications for IGF-1 LR3 research use

They say that robust, independently-funded randomised controlled trials with long follow-up times that include people diagnosed with binge eating disorders are still needed to clarify the potential clinical role of these drugs to help treat binge eating disorder, and to determine whether the observed short-term benefits translate into meaningful and sustained improvements

No math at home